ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Get Free Report) shares fell 1.5% during trading on Monday . The company traded as low as $29.85 and last traded at $30.14. 36,777 shares changed hands during trading, an increase of 202% from the average session volume of 12,197 shares. The stock had previously closed at $30.59.
ALPS Medical Breakthroughs ETF Trading Up 1.3 %
The stock has a 50-day moving average price of $32.01 and a 200 day moving average price of $35.61.
Institutional Trading of ALPS Medical Breakthroughs ETF
Hedge funds and other institutional investors have recently made changes to their positions in the company. Farther Finance Advisors LLC increased its position in ALPS Medical Breakthroughs ETF by 3,789.1% in the 4th quarter. Farther Finance Advisors LLC now owns 4,978 shares of the company’s stock valued at $164,000 after acquiring an additional 4,850 shares during the period. McGuire Investment Group LLC increased its position in ALPS Medical Breakthroughs ETF by 28.1% in the 4th quarter. McGuire Investment Group LLC now owns 10,310 shares of the company’s stock valued at $341,000 after acquiring an additional 2,260 shares during the period. Jane Street Group LLC acquired a new position in ALPS Medical Breakthroughs ETF in the 3rd quarter valued at about $366,000. GTS Securities LLC acquired a new position in ALPS Medical Breakthroughs ETF in the 4th quarter valued at about $1,383,000. Finally, Wells Fargo & Company MN increased its position in ALPS Medical Breakthroughs ETF by 0.3% in the 4th quarter. Wells Fargo & Company MN now owns 126,721 shares of the company’s stock valued at $4,186,000 after acquiring an additional 334 shares during the period.
ALPS Medical Breakthroughs ETF Company Profile
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.
See Also
- Five stocks we like better than ALPS Medical Breakthroughs ETF
- How to Invest in Blue Chip Stocks
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- With Risk Tolerance, One Size Does Not Fit All
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.
